Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

Preferences on cigarette plain packaging among adults who smoke and adults who do not smoke: a discrete choice experiment in Chile.
(2026 Oct 1)
Tob Control
Araya-Ríos D, Paraje G, Hancock TO, Mentzakis E

Response to 'Oral health in cancer palliative care: cross-sectional study'.
(2026 Oct 1)
BMJ Support Palliat Care
Watts E, Hannon M, Cleary N

Natural History After Likely Cure Versus Recurrence After Prostate Radiotherapy (RAPTOR).
(2026 Oct 1)
Eur Urol Oncol
Roy S, Romero T, Roach M 3rd, Michalski JM, Joseph DJ, Dearnaley D, Tree AC, Hall E, Sydes MR, Incrocci L, Heemsbergen W, de Pos F, Bolla M, Maingon P, de Reijke T, Nabid A, Armstrong JG, Morgan SC, Maldonado X, Ong WL, Martin J, Horwitz EM, Wong JK, Steinberg M, Valle L, Taparra K, Jia AY, Zaorsky NG, Arcangeli S, Sanguineti G, Zapatero A, Sandler H, Nguyen PL, Sun Y, Spratt DE, Kishan AU

Sonelokimab, a novel IL-17A- and IL-17F-inhibiting nanobody for the treatment of moderate-to-severe hidradenitis suppurativa: a global, randomized, double-blind, placebo-controlled phase 2 clinical trial (MIRA).
(2026 Oct 1)
J Am Acad Dermatol
Kimball AB, Bechara FG, Porter ML, Prens E, Jemec GBE, Krueger JG, Szepietowski JC, Gooderham MJ, Pinter A, Gordon KB, Brennan N, Godwood A, Cullen E, Reich K, Kirby B

Integrating sexual health into sickle cell disease care.
(2026 Oct)
Lancet Haematol 13(10): e697
Pellegrini M, Roy NBA, Nogueira Santos de Oliveira Freire M, Gulbis B, Mañu Pereira MDM, ERN-EuroBloodNet ASCAT 2025 Working Group

Show complete publication list

In the News